Chemed Corporation

DB:CXM Stock Report

Market Cap: €7.5b

Chemed Past Earnings Performance

Past criteria checks 5/6

Chemed has been growing earnings at an average annual rate of 1.8%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 3.5% per year. Chemed's return on equity is 24.4%, and it has net margins of 12.7%.

Key information

1.8%

Earnings growth rate

3.4%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate3.5%
Return on equity24.4%
Net Margin12.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Chemed makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:CXM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242,3773024150
30 Jun 242,3363014130
31 Mar 242,2932834110
31 Dec 232,2642733950
30 Sep 232,2252453920
30 Jun 232,1872263760
31 Mar 232,1652403690
31 Dec 222,1352503590
30 Sep 222,1292623540
30 Jun 222,1412773590
31 Mar 222,1422673650
31 Dec 212,1392693670
30 Sep 212,1323083610
30 Jun 212,1213033610
31 Mar 212,0913293510
31 Dec 202,0803193300
30 Sep 202,0692713220
30 Jun 202,0212633110
31 Mar 201,9922312980
31 Dec 191,9392203060
30 Sep 191,8742092890
30 Jun 191,8372012790
31 Mar 191,8062052760
31 Dec 181,7832062710
30 Sep 181,7532062760
30 Jun 181,7271902750
31 Mar 181,7001132710
31 Dec 171,667982710
30 Sep 171,642762610
30 Jun 171,617672540
31 Mar 171,5921142490
31 Dec 161,5771092380
30 Sep 161,5721062400
30 Jun 161,5661082340
31 Mar 161,5571112330
31 Dec 151,5431102330
30 Sep 151,5241102290
30 Jun 151,4961062290
31 Mar 151,4751032240
31 Dec 141,456992200
30 Sep 141,425922160
30 Jun 141,408852110
31 Mar 141,405762100
31 Dec 131,413772130

Quality Earnings: CXM has high quality earnings.

Growing Profit Margin: CXM's current net profit margins (12.7%) are higher than last year (11%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CXM's earnings have grown by 1.8% per year over the past 5 years.

Accelerating Growth: CXM's earnings growth over the past year (23.4%) exceeds its 5-year average (1.8% per year).

Earnings vs Industry: CXM earnings growth over the past year (23.4%) did not outperform the Healthcare industry 40.5%.

Return on Equity

High ROE: CXM's Return on Equity (24.4%) is considered high.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 08:34
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chemed Corporation is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ishan MajumdarBaptista Research
Adam FeinsteinBarclays
Joanna Sylvia GajukBofA Global Research